Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125690001 | 12569000 | 1 | I | 20160625 | 20160711 | 20160719 | 20160719 | EXP | GB-ASTRAZENECA-2016SE75079 | ASTRAZENECA | 67.00 | YR | F | Y | 62.60000 | KG | 20160719 | CN | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125690001 | 12569000 | 1 | PS | ROSUVASTATIN CALCIUM. | ROSUVASTATIN CALCIUM | 1 | Oral | 5.0MG UNKNOWN | U | U | 21366 | 5 | MG | TABLET | |||||
125690001 | 12569000 | 2 | C | PRAVASTATIN. | PRAVASTATIN | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125690001 | 12569000 | 1 | Type IIa hyperlipidaemia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125690001 | 12569000 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125690001 | 12569000 | Cardiac flutter | |
125690001 | 12569000 | Dyspnoea | |
125690001 | 12569000 | Muscle spasms | |
125690001 | 12569000 | Muscle twitching | |
125690001 | 12569000 | Muscular weakness | |
125690001 | 12569000 | Musculoskeletal stiffness | |
125690001 | 12569000 | Myalgia | |
125690001 | 12569000 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125690001 | 12569000 | 1 | 20160622 | 0 |